Halozyme Therapeutics, Inc. (HALO) Financial Statements (2024 and earlier)

Company Profile

Business Address 12390 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments362,794740,922368,013120,179354,526469,214
Cash and cash equivalents234,195118,719147,703120,17957,936168,740
Short-term investments 128,599622,203220,310 296,590300,474
Receivables231,07290,97597,73059,44230,00522,133
Inventory, net of allowances, customer advances and progress billings100,12353,90860,74729,35922,6255,146
Inventory100,12353,90860,74729,35922,6255,146
Prepaid expense   30,1568,2302,337
Contract with customer, asset, after allowance for credit loss     
Derivative instruments and hedges, assets      
Other undisclosed current assets45,02440,48228,274304,30012,46311,542
Total current assets:739,013926,287554,764543,436427,849510,372
Noncurrent Assets
Operating lease, right-of-use asset40,4692,003  
Property, plant and equipment35,1016,79110,59310,8557,4653,520
Intangible assets, net (including goodwill)955,701     
Goodwill409,049     
Intangible assets, net (excluding goodwill)546,652     
Derivative instruments and hedges      
Restricted cash and investments 500500500500500500
Deferred income tax assets44,426155,434  
Other undisclosed noncurrent assets26,30113,41414,06711,0834,4345,553
Total noncurrent assets:1,102,498178,14225,16022,43812,3999,573
TOTAL ASSETS:1,841,5111,104,429579,924565,874440,248519,945
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities114,20925,98222,41162,08353,60847,549
Accounts payable17,6931,5411,9286,4344,0797,948
Accrued liabilities96,51624,44120,48355,64949,52939,601
Deferred revenue3,2461,7461,746 
Debt 13,33489,419397,22819,54291,50677,211
Deferred revenue and credits4,2476,568
Other undisclosed current liabilities    4,012  
Total current liabilities:130,789117,147421,38585,637149,361131,328
Noncurrent Liabilities
Long-term debt and lease obligation1,492,766787,255 383,045  
Long-term debt, excluding current maturities1,492,766787,255 383,045  
Liabilities, other than long-term debt48,1583,0747,4925,4277,12655,111
Deferred revenue and credits5,00854,297
Deferred revenue2,2532,5304,0261,247
Other liabilities30,4335443,4664,1802,118814
Business combination, contingent consideration, liability 15,472     
Total noncurrent liabilities:1,540,924790,3297,492388,4727,12655,111
Total liabilities:1,671,713907,476428,877474,109156,487186,439
Equity
Equity, attributable to parent169,798196,953151,04791,765248,887208,366
Common stock135138135137145143
Additional paid in capital27,368256,347625,483695,066780,457731,044
Accumulated other comprehensive income (loss)(922)(620)22240(277)(450)
Retained earnings (accumulated deficit)143,217(58,912)(474,593)(603,678)(531,438)(522,371)
Total equity:169,798196,953151,04791,765248,887208,366
Other undisclosed liabilities and equity     34,874125,140
TOTAL LIABILITIES AND EQUITY:1,841,5111,104,429579,924565,874440,248519,945

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues660,116443,310267,594195,992151,862316,613
Revenue, net151,862316,613
Cost of revenue
(Cost of Goods and Services Sold)
(139,304)(81,413)(43,367)(45,546)(10,136)(31,152)
Gross profit:520,812361,897224,227150,446141,726285,461
Operating expenses(253,281)(85,995)(79,972)(218,056)(211,056)(204,459)
Operating income (loss):267,531275,902144,255(67,610)(69,330)81,002
Nonoperating income1,0461,1025,4256,9867,5772,592
Other nonoperating income1,0461,1025,4256,9867,5782,592
Interest and debt expense(19,659)(28,486)(20,378)(12,028)(18,041)(21,984)
Income (loss) from continuing operations before equity method investments, income taxes:248,918248,518129,302(72,652)(79,794)61,610
Other undisclosed income from continuing operations before income taxes   4011 
Income (loss) from continuing operations before income taxes:248,918248,518129,302(72,251)(79,793)61,610
Income tax expense (benefit)(46,789)154,192(217)11(537)1,361
Income (loss) from continuing operations:202,129402,710129,085(72,240)(80,330)62,971
Income (loss) before gain (loss) on sale of properties:402,710129,085(72,240)(80,330)62,971
Net income (loss) available to common stockholders, diluted:202,129402,710129,085(72,240)(80,330)62,971

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):202,129402,710129,085(72,240)(80,330)62,971
Other comprehensive income (loss)815(32)9(8)(14)
Comprehensive income (loss):202,137402,725129,053(72,231)(80,338)62,957
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(310)(657)(186)508181(430)
Comprehensive income (loss), net of tax, attributable to parent:201,827402,068128,867(71,723)(80,157)62,527

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: